Aspen Shares Nosedive 15% on JSE After Shock Profit Warning

Shares in pharmaceutical giant Aspen Pharmacare took a sharp dive in early trading on Friday. They slumped by as much as 15% after the company issued a profit warning for its financial year ending in June. The announcement cited significant impairments totalling R4.1...

Adcock Ingram Reports Flat Profit Despite Winter Surge

Pharmaceutical giant Adcock Ingram has announced flat annual profits despite a significant recovery in the second half of its financial year. This was buoyed by strong demand for its popular over-the-counter winter medicines. In a landmark move, the maker of household...

Pharma Giants Sidelined in R15.5bn HIV Drug Tender

The National Department of Health has awarded its latest three-year antiretroviral (ARV) tender, valued at R15.5 billion. This decision leaves several of South Africa’s largest domestic pharmaceutical manufacturers without a contract. The government’s...

Public Health Reform: Urgent Changes Needed

The chair of Parliament’s portfolio committee on health, Dr Sibongiseni Dhlomo, has called for urgent legislative reform. This is to tackle the escalating disruptions at public health facilities by activists from Operation Dudula. The call comes as the group...

TB Deaths in South Africa Persist Despite Drop in Infections

Tuberculosis (TB) remains South Africa’s most lethal infectious disease. TB deaths claimed an estimated 56,000 lives in 2023. This occurred even as the number of new infections saw a sharp decline, health officials have revealed. The stark figures highlight a growing...